LENZ Therapeutics News

LENZ Therapeutics | EFFECT: Others

Sep 20 18:02

LENZ Therapeutics | 424B3: Prospectus

Sep 20 05:05

LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Sep 12 04:12

LENZ Therapeutics | 424B3: Prospectus

Aug 15 04:32

LENZ Therapeutics | 10-Q: Quarterly report

Aug 15 04:21

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 15 04:10

LENZ Therapeutics | 424B3: Prospectus

Aug 12 20:15

LENZ Therapeutics | 8-K: Current report

Aug 12 20:10

LENZ Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ridgeback Capital Investments L.P.(7.2%),Ridgeback Capital Investments LLC(7.2%), etc.

Jul 30 04:16

LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schimmelpennink Evert B.

Jul 24 08:20

LENZ Therapeutics | 424B3: Prospectus

Jul 15 20:34

LENZ Therapeutics | 8-K: Current report

Jul 15 20:24

LENZ Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 21 20:35

LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chevallard Daniel R.

May 16 04:22

LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MCCOLLUM JAMES W

May 15 05:35

LENZ Therapeutics | 424B3: Prospectus

May 10 04:24

LENZ Therapeutics | 10-Q: Quarterly report

May 9 05:17

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 9 04:10

LENZ Therapeutics | 424B3: Prospectus

Apr 12 02:36

LENZ Therapeutics | EFFECT: Others

Apr 11 18:05